A paradigm shift in enteric coating: Achieving rapid release in the proximal small intestine of man

Journal of Controlled Release

Volumn 147, Issue 2, 2010, Pages 242-245

  Liu, Fang ^a   Basit, Abdul W ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Enteric coatings; Enteric polymers; Gamma scintigraphy; Gastric resistance; Gastrointestinal transit; Methacrylic acid ethyl acrylate copolymer; PH sensitive polymers

Indexed keywords

ENTERIC POLYMER; ENTERIC-COATING; GAMMA SCINTIGRAPHY; GASTRIC RESISTANCE; GASTROINTESTINAL TRANSIT; METHACRYLIC ACIDS; PH-SENSITIVE POLYMERS;

CITRIC ACID; COPOLYMERIZATION; NUCLEAR MEDICINE; POLYMERS;

PLASTIC COATINGS;

EUDRAGIT;

ADULT; ARTICLE; COMPARATIVE STUDY; DRUG FORMULATION; DRUG RELEASE; ENTERIC COATED TABLET; GAMMA SCINTIGRAPHY; HUMAN; ISOTOPE LABELING; MALE; NORMAL HUMAN; PH; PRIORITY JOURNAL; SMALL INTESTINE; STOMACH EMPTYING;

ADULT; CROSS-OVER STUDIES; DRUG CARRIERS; DRUG COMPOUNDING; GASTRIC EMPTYING; HUMANS; INTESTINE, SMALL; MALE; METHACRYLATES; RADIOISOTOPES; SOLUBILITY; TABLETS, ENTERIC-COATED; TIME FACTORS; YOUNG ADULT;

EID: 77957021284     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2010.07.105     Document Type: Article

References (24)

1. Agyilirah G.A., Banker G.S. Polymers for enteric coating and applications. Polymers for Controlled Drug Delivery 1991, 39-66. CRC Press, Baca Raton. P.J. Tarcha (Ed.).
2. McConnell E.L., Fadda H.M., Basit A.W. Gut instincts: explorations in intestinal physiology and drug delivery. Int. J. Pharm. 2008, 364:213-226.
3. Catteau D., Barthelemy C., Deveaux M., Robert H., Trublin F., Marchandise X., Drunen H.V. Contribution of scintigraphy to verify the reliability of different preparation processes for enteric coated capsules. Eur. J. Drug Metab. Pharmacokinet. 1994, 19:91-98.
4. Kenyon C.J., Cole E.T., Wilding I.R. The effect of food on the in vivo behaviour of enteric coated starch capsules. Int. J. Pharm. 1994, 112:207-213.
5. Bogentoft C., Alpsten M., Ekenved G. Absorption of acetylsalicylic acid from enteric-coated tablets in relation to gastric emptying and in-vivo disintegration. J. Pharm. Pharmacol. 1984, 36:350-351.
6. Wilding I.R., Hardy J.G., Sparrow R.A., Davis S.S., Daly P.B., English J.R. In vivo evaluation of enteric-coated naproxen tablets using gamma scintigraphy. Pharm. Res. 1992, 9:1436-1441.
7. Cole E.T., Scott R.A., Connor A.L., Wilding I.R., Petereit H.-U., Schminke C., Beckert T., Cade D. Enteric coated HPMC capsules designed to achieve intestinal targeting. Int. J. Pharm. 2002, 231:83-95.
8. Ebel J.P., Jay M., Beihn R.M. An in vitro/in vivo correlation for the disintegration and onset of drug release from enteric-coated pellets. Pharm. Res. 1993, 10:233-238.
9. Wilding I.R., Davis S.S., Sparrow R.A., Smith K.J., Sinclair K.A., Smith A.T. The evaluation of an enteric-coated naproxen tablet formulation using gamma scintigraphy. Eur. J. Pharm. Biopharm. 1993, 39:144-147.
10. Liu F., Lizio R., Meier C., Petereit H.-U., Blakey P., Basit A.W. A novel concept in enteric coating: a double-coating system providing rapid drug release in the proximal small intestine. J. Control Release 2009, 133:119-124.
11. Liu F., Lizio R., Schneider U.U., Petereit H.-U.P., Blakey, Basit A.W. SEM/EDX and confocal microscopy analysis of novel and conventional enteric coated systems. Int. J. Pharm. 2009, 369:72-78.
12. Liu F., Moreno P., Basit A.W. A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract. Eur. J. Pharm. Biopharm. 2010, 74:311-315.
13. Khosla R., Davis S.S. Gastric emptying and small and large bowel transit of non-disintegrating tablets in fasted subjects. Int. J. Pharm. 1989, 52:1-10.
14. Fadda H.M., McConnell E.L., Short M.D., Basit A.W. Meal-induced acceleration of tablet transit through the human small intestine. Pharm. Res. 2009, 26:356-360.
15. Davis S.S., Norring-Christensen F., Khosla R., Feely L.C. Gastric emptying of large single unite dosage forms. J. Pharm. Pharmacol. 1988, 40:205-207.
16. Ibekwe V.C., Liu F., Fadda H.M., Khela M.K., Evans D.F., Parsons G.E., Basit A.W. An investigation into the in vivo performance variability of pH responsive polymers for ileo-colonic drug delivery using gamma scintigraphy in humans. J. Pharm. Sci. 2006, 95:2760-2766.
17. Steed K.P., Hooper G., Ventura P., Musa R., Wilding I.R. The in vivo behaviour of a colonic delivery system: a pilot study in man. Int. J. Pharm. 1994, 112:199-206.
18. Ibekwe V.C., Fadda H.M., McConnell E.L., Khela M.K., Evans D.F., Basit A.W. Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileo-colonic release systems. Pharm. Res. 2008, 25:1828-1835.
19. Damle B.D., Kaul S., Behr D., Knupp C. Bioequivalence of two formulations of didanosine, encapsulated enteric-coated beads and buffered tablet, in healthy volunteers and HIV-infected subjects. J. Clin. Pharmacol. 2002, 42:791-797.
20. Guarner L., Rodriguez R., Guarner F., Malagelada J.-R. Fate of oral enzymes in pancreatic insufficiency. Gut 1993, 34:708-712.
21. Gundert-Remy U., Hildebrandt R., Stiehl A., Weber E., Zurcher G., Prada M.D. Intestinal absorption of levodopa in man. Eur. J. Clin. Pharmacol. 1983, 25:69-72.
22. Marotta F., O'Keefe S.J.D., Marks I.N., Girdwood A., Young G. Pancreatic enzyme replacement therapy. Importance of gastric acid secretion, H2-antagonists, and enteric coating. Dig. Dis. Sci. 1989, 34:456-461.
23. Robinson P.J., Smith A.L., Sly P.D. Duodenal pH in cystic fibrosis and its relationship to fat malabsorption. Dig. Dis. Sci. 1990, 35:1299-1304.
24. Castell D. Review of immediate-release omeprazole for the treatment of gastric acid-related disorders. Expert Opin. Pharmacother. 2005, 6:2501-2510.